Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis

ClinicalTrials.gov ID: NCT00097188

Public ClinicalTrials.gov record NCT00097188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 9, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab (Mabthera/Rituxan) in Adults With Relapsing Remitting Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase II, randomized, double-blind, parallel group, placebo controlled, multicenter study to evaluate the safety and efficacy of Rituximab in adults with RRMS.

Study identification

NCT ID
NCT00097188
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
104 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2004 (Type not available)
Primary completion
Not listed
Completion
Dec 2006 (Actual)
Last update posted
Mar 4, 2014

2004 – 2006

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Phoenix Neurological Associates Phoenix Arizona 85006 —
Loma Linda University Loma Linda California 92354 —
Sutter Gould Medical Foundation Modesto California 95355 —
University Of California At Davis Sacramento California 95817 —
Neurological Research Institute Of East Bay Walnut Creek California 94596 —
Neurology Associates, P.A. Maitland Florida 32751 —
Multiple Sclerosis Center of Brevard Melbourne Florida 32940 —
Neurological Services Of Orlando Orlando Florida 32806 —
Neurological Associates Pompano Beach Florida 33060 —
MS Center of Vero Beach Vero Beach Florida 32960 —
MS Center Of Atlanta Atlanta Georgia 30327 —
Medical College of Georgia Augusta Georgia 30912 —
University Of Kansas Medical Center Kansas City Kansas 66160 —
Kentucky Neuroscience Research Louisville Kentucky 40202 —
University of Maryland Hospital MS Center Baltimore Maryland 21201 —
Michigan Institute For Neurological Disorders Farmington Hills Michigan 48334 —
Deaconess Billings Clinical Research Division Billings Montana 59101 —
Albany Medical Center Albany New York 12208 —
Meritcare Neuroscience Clinic Fargo North Dakota 58103 —
Neurology and Neuroscience Assoc.,INC Akron Ohio 44302 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
The Ohio State University Columbus Ohio 43221 —
Geisinger Medical Center Danville Pennsylvania 17822 —
University Of Pennsylvania Medical Center Philadelphia Pennsylvania 19104 —
Neurology Specialists of Dallas, PA Dallas Texas 75231 —
Maxine Mesinger MS Clinic/ Baylor College of Medicine Houston Texas 77030 —
Neurology Clinic of San Antonio San Antonio Texas 78229 —
Virginia Mason Medical Center Seattle Washington 98101 —
Holy Family MS Center Spokane Washington 99208 —
Neurology and Neurosurgery Associates of Tacoma, Inc., P.S. Tacoma Washington 98405 —
St. Luke's Medical Center/Center for Neurological Disorders Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00097188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 4, 2014 · Synced Oct 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00097188 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →